RUZURGI

This brand name is authorized in Canada, United States

Active ingredients

The drug RUZURGI contains one active pharmaceutical ingredient (API):

1 Amifampridine UNII RU4S6E2G0J - AMIFAMPRIDINE

Amifampridine blocks voltage-dependent potassium channels, thereby prolonging pre-synaptic cell membrane depolarisation. Prolonging the action potential enhances the transport of calcium into the nerve ending. The resulting increase in intra-cellular calcium concentrations facilitates exocytosis of acetylcholine-containing vesicles, which in turn enhances neuromuscular transmission. Read about Amifampridine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RUZURGI Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX05	Amifampridine	N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02503034
Country: US	FDA, National Drug Code	Identifier(s): 49938-110